Sign in

CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
520845822
Phone
352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. DEFA14A Proxy Proxy Materials
  2. 424B5 Offering Prospectus
  3. 4 Open-market buy Director bought 11,112 shares at $0.21 ($2,356)
  4. 4 Grant or award Director acquired 22,645 shares (grant or award)
  5. 4 Grant or award Director acquired 22,645 shares (grant or award)
  6. 4 Grant or award Director acquired 22,645 shares (grant or award)
  7. DEFA14A Proxy Proxy Materials
  8. DFAN14A Other Proxy Soliciting Materials
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. 8-K Event Regulation FD disclosure · Other events
  12. DFAN14A Other Proxy Soliciting Materials
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. DFAN14A Other Proxy Soliciting Materials
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. UPLOAD Other SEC-generated Letter
  18. 4 Open-market buy CEO & President bought 85,000 shares at $0.20 ($16,915)
  19. 4 Open-market buy Director bought 81,953 shares at $0.19 ($15,817)
  20. DFAN14A Other Proxy Soliciting Materials

Page 10 of 82 · 1,637 filings